Go Pro

Doximity (DOCS) Stock Price, News & Analysis

Doximity logo
$21.00 -0.24 (-1.13%)
As of 03:09 PM Eastern
This is a fair market value price provided by Massive. Learn more.

About Doximity Stock (NYSE:DOCS)

Advanced

Key Stats

Today's Range
$20.71
$21.36
50-Day Range
$19.52
$22.92
52-Week Range
$17.15
$76.51
Volume
1.19 million shs
Average Volume
3.68 million shs
Market Capitalization
$3.84 billion
P/E Ratio
21.21
Dividend Yield
N/A
Price Target
$29.33
Consensus Rating
Hold

Company Overview

Doximity, trading as DOCS, operates a digital professional network and communications platform designed primarily for clinicians. Headquartered in San Francisco, the company connects physicians, nurse practitioners, physician assistants and other healthcare professionals, providing tools that streamline clinical communication, telehealth delivery and access to specialty-specific medical information. Its platform is positioned as a professional hub where clinicians manage their workflows, stay current with medical news and collaborate securely with peers.

The company’s offerings include secure messaging and video telehealth capabilities that enable clinicians to consult with patients and colleagues while protecting patient information. Doximity also provides mobile calling and faxing tools that let clinicians place calls from their personal devices using a professional number, and a searchable physician directory used by members and institutions. In addition to clinical communications, the platform hosts medical news and educational content, tools for earning continuing medical education (CME) credits, and resources that support medical training and career development.

Doximity supports recruitment and talent solutions for healthcare organizations through a marketplace that helps employers identify and engage clinical candidates. It also publishes research and insights drawn from its professional network to inform healthcare trends, residency selection and workforce planning. The company primarily serves the U.S. healthcare market, where its network of licensed clinicians is concentrated, and partners with hospitals, health systems and medical institutions to deploy its enterprise services.

Since becoming a public company in 2021, Doximity has positioned itself at the intersection of clinical workflow, professional networking and digital health services. Its business emphasizes product expansion that addresses clinician communication needs and institutional recruiting and marketing requirements while maintaining a focus on privacy and professional standards for healthcare users.

AI Generated. May Contain Errors.

Doximity Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
84th Percentile Overall Score

DOCS MarketRank™: 

Doximity scored higher than 84% of companies evaluated by MarketBeat, and ranked 145th out of 901 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Doximity has received a consensus rating of Hold. The company's average rating score is 2.29, and is based on 2 strong buy ratings, 6 buy ratings, 13 hold ratings, and 3 sell ratings.

  • Upside Potential

    Doximity has a consensus price target of $29.33, representing about 39.8% upside from its current price of $20.99.

  • Amount of Analyst Coverage

    Doximity has been the subject of 19 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Doximity's stock forecast and price target.
  • Earnings Growth

    Earnings for Doximity are expected to grow by 10.34% in the coming year, from $0.87 to $0.96 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Doximity is 21.16, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 39.99.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Doximity is 21.16, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 281.54.

  • Price to Earnings Growth Ratio

    Doximity has a PEG Ratio of 7.85. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Doximity has a P/B Ratio of 4.04. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Doximity's valuation and earnings.
  • Percentage of Shares Shorted

    16.62% of the float of Doximity has been sold short.
  • Short Interest Ratio / Days to Cover

    Doximity has a short interest ratio ("days to cover") of 7.39.
  • Change versus previous month

    Short interest in Doximity has recently increased by 5.25%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Doximity does not currently pay a dividend.

  • Dividend Growth

    Doximity does not have a long track record of dividend growth.

  • News Sentiment

    Doximity has a news sentiment score of 1.29. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.87 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 6 news articles for Doximity this week, compared to 6 articles on an average week.
  • Search Interest

    Only 8 people have searched for DOCS on MarketBeat in the last 30 days. This is a decrease of -20% compared to the previous 30 days.
  • MarketBeat Follows

    4 people have added Doximity to their MarketBeat watchlist in the last 30 days. This is an increase of 300% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Doximity insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $343,925.00 in company stock.

  • Percentage Held by Insiders

    31.80% of the stock of Doximity is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    87.19% of the stock of Doximity is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Doximity's insider trading history.
Receive DOCS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Doximity and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

DOCS Stock News Headlines

2 Reasons to Like DOCS (and 1 Not So Much)
Porter flew 3,300 miles to investigate this system
Porter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experiment called Project Prophet - and documented everything on film. Rooted in the laws of physics, this quantitative approach challenges conventional wealth-building wisdom. With 17 years of verified data behind it, Porter calls it unlike anything he has seen in nearly 30 years in the business.tc pixel
Doximity, Inc. ($DOCS) CEO 2026 Pay Revealed
RBC Capital Sticks to Their Buy Rating for Doximity (DOCS)
See More Headlines

DOCS Stock Analysis - Frequently Asked Questions

Doximity's stock was trading at $44.26 on January 1st, 2026. Since then, DOCS shares have decreased by 52.6% and is now trading at $20.9850.

Doximity, Inc. (NYSE:DOCS) released its quarterly earnings data on Thursday, February, 5th. The company reported $0.46 EPS for the quarter, topping the consensus estimate of $0.45 by $0.01. The business's revenue for the quarter was up 9.8% compared to the same quarter last year.
Read the conference call transcript
.

Doximity's board initiated a stock buyback plan on Thursday, February 5th 2026, which permits the company to buy back $500,000,000 in shares, according to EventVestor. This means that the company could repurchase up to 8% of its shares through open market purchases. Shares buyback plans are generally an indication that the company's leadership believes its shares are undervalued.

Doximity (DOCS) raised $501 million in an IPO on Thursday, June 24th 2021. The company issued 23,300,000 shares at $20.00-$23.00 per share. Morgan Stanley, Goldman Sachs and J.P. Morgan Securities served as the underwriters for the IPO and Piper Sandler, William Blair, Canaccord and Raymond James were co-managers.

Top institutional investors of Doximity include Handelsbanken Fonder AB (0.02%), Central Pacific Bank Trust Division and GAMMA Investing LLC. Insiders that own company stock include Anna Bryson, Craig Overpeck, Siddharth Sitaram, Regina M Benjamin, Kira Scherer Wampler, Watkin Phoebe L Yang and Timothy S Cabral.
View institutional ownership trends
.

Shares of DOCS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Doximity investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Meta Platforms (META), Tesla (TSLA), CrowdStrike (CRWD), PayPal (PYPL) and Invesco QQQ (QQQ).

Company Calendar

Last Earnings
2/05/2026
Today
7/31/2026
Next Earnings (Confirmed)
8/06/2026
AGM 2026
8/27/2026
Fiscal Year End
3/31/2027

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Healthcare Technology
Sub-Industry
Healthcare Technology
Current Symbol
NYSE:DOCS
Previous Symbol
NASDAQ:DOCS
CIK
1516513
Web
N/A
Fax
N/A
Employees
890
Year Founded
2010

Price Target and Rating

High Price Target
$65.00
Low Price Target
$18.00
Potential Upside/Downside
+39.8%
Consensus Rating
Hold
Rating Score (0-4)
2.29
Research Coverage
24 Analysts

Profitability

EPS (Trailing Twelve Months)
$0.99
Trailing P/E Ratio
21.16
Forward P/E Ratio
24.12
P/E Growth
7.85
Net Income
$196.05 million
Net Margins
30.40%
Pretax Margin
38.77%
Return on Equity
20.40%
Return on Assets
17.43%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
6.09
Quick Ratio
6.09

Sales & Book Value

Annual Sales
$644.86 million
Price / Sales
5.95
Cash Flow
$1.20 per share
Price / Cash Flow
17.45
Book Value
$5.19 per share
Price / Book
4.04

Miscellaneous

Outstanding Shares
182,870,000
Free Float
124,719,000
Market Cap
$3.84 billion
Optionable
N/A
Beta
1.30

Social Links

7 Stocks That Will Be Magnificent in 2026 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NYSE:DOCS) was last updated on 7/31/2026 by MarketBeat.com Staff.
From Our Partners